SLC5A2 and type 2 diabetes mellitus: The present study’s purpose, which was a sub-analysis of the PROTECT study, was to determine the impacts of 24 months of treatment using SGLT2 inhibitors on endothelial function as measured by FMD in the brachial artery in patients with type 2 diabetes.